Sandbox Reserved 1134: Difference between revisions

Line 1:

{{Sandbox_Reserved_ESBS_2015}}

~~==Your Heading Here (maybe something like 'Structure')==~~

== Function and Structure ==

~~This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the <~~ and ~~> signs.~~

~~You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.~~

~~== Function ==~~

'''Human synthetic monocyte chemoattractant protein 1 (MCP)''' belongs to the superfamily of chemokines, which are proteins involved in immunoregulatory and inflammatory processes. On chromosome 17 in region 17q11.2-q12 is the gene MCP1. The superfamily can be subdivided into 4 smaller groups, depending on the N-ter arangment of the cysteines. The MCP1<ref>PMID:8170963</ref> is also known as '''chemokine (C-C motif) ligand''' or: <br>

- MCP1 <br>

- small inducible cytokine A2 (SCYA2)<br>

- MCAF <br>

- GDCF-2 <br>

- SMC-CF <br>

- HSMCR30 <br>

- MGC9434 <br>

- GDCF-2 <br>

- HC11 <br>

=~~= Disease ==~~

It exists as a monomer or a dimer, eventhough the homodimer form is preferred.

The structure of the monomer is made of <scene name='72/721520/Ligand_binding_on_ccl2/2'>3 Beta sheets and 1 alpha helix</scene>.

== ~~Relevance~~ ==

== Action principle ==

MCP1 is secreted thanks to variety of cells including endothelial cells, fibroblasts, epithelial, and smooth muscle. It acts by attracting some of the immune cells like monocytes and lymphocytes. Theses cells are equipped with a CCR2 receptor coupled with a G protein which can recuits MCP1.

MCP1 apply its chemotaxis power thanks to a concentration gradient : immune cells move from region with low concentration of MCP1 to region where a lot of MCP1 is secreted. Monocytes will then themselves be matured in macrophage which are able to secrete MCP1 in order to recruit more immune cells on the damage tissue.

== Ligands ==

To see the ligands it binds to, please show the <scene name='72/721520/Ligand_binding_on_ccl2/1'>monomer structure</scene> and then show the binding sites for <scene name='pdbligand=K:POTASSIUM+ION'>potassium</scene> and <scene name='pdbligand=PO4:PHOSPHATE+ION'>phosphate</scene> ions. The PO4 binds to the K35, S33 and S34 of the monomer and K binds to F15, N14 and N17.

== Evolutionary Conservation ==

[[Image:Consurf_key_small.gif|200px|right]]

Check<jmol>

<scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/if/3ifd_consurf.spt"</scriptWhenChecked>

<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>

<text>to colour the structure by Evolutionary Conservation</text>

</jmolCheckbox>

</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB].

== Diseases ==

MCP1 is implicated in several diseases like psoriasis and rheumatoid arthritis where the appear to recruit macrophages, therefore bolstering the inflammation on joints.

It is thought to be involved in atherosclerosis in the recruitment of monocytes into the arterial wall as well as in prostate cancer<ref>PMID:25917126</ref>.

It has also been found elevated in the urine of people with lupus as a sign warning of inflammation of the kidney.

MCP1 is overexpressed in epilepsy, brain ischemia, Alzheimer's disease, EAE and traumatic brain injury.

== Structural highlights ==

~~This~~ is ~~a sample scene created with SAT to~~ <scene name="/12/~~3456~~/~~Sample~~/1">~~color~~</~~scene~~> ~~by Group,~~ and ~~another~~ to ~~make~~ <~~scene name="~~/~~12/3456/Sample/2"~~>a ~~transparent representation</scene>~~ of the ~~protein. You can make your own scenes on SAT starting from scratch or loading~~ and ~~editing~~ one of these ~~sample scenes~~.

MCP1 is part of the C-C motif group because of the covalent bond made between <scene name='72/721520/Cv/4'>2 of the 4 cysteines of the N terminal domain</scene>.<ref>PMID:8989326</ref>

Post translational modifications at the N-terminus can regulate receptor and target cell selectivity. Deletion of the N-terminal residue converts it from an activator of basophil to an eosinophil chemoattractant.

</StructureSection>

[[Image:chaine.png]]

== Synthesis ==

Thanks to a combination of solid phase peptide synthesis (SPPS) and native chemical ligation (NCL), MCP1 was synthesized. Its thioester-peptide segment was made using the sulfonamide safety-catch linker and 9-fluorenylmethoxycarbonyl (Fmoc) SPPS and that is probably one of the first crystal structures prepared using these techniques. To facilitate the synthesis of both MCP1 fragments, pseudoproline dipeptides were used. Then, NCL was used to assembly the all chain and MCP1 was folded and oxidized by a glutathione redox buffer.

MCP1 was crystallized and the structure was determined by X-ray diffraction at 1.9-A resolution.

~~</StructureSection>~~

== References ==

https://fr.wikipedia.org/wiki/CCL2

http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/GetPage.pl?pdbcode=1DOK

http://www.uniprot.org/uniprot/P13500#interaction

http://www.rcsb.org/pdb/explore/explore.do?structureId=3IFD

Sandbox Reserved 1134: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
 {{Sandbox_Reserved_ESBS_2015}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
-==Your Heading Here (maybe something like 'Structure')==
+<StructureSection load='1dok' size='350' side='right' caption='Monocyte chemoattractant protein 1 (PDB code [[3idf]])' scene='72/721520/Cv/2'>
-<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
+== Function and Structure ==
-This is a default text for your page ''''''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
-You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
-== Function ==
+'''Human synthetic monocyte chemoattractant protein 1 (MCP)''' belongs to the superfamily of chemokines, which are proteins involved in immunoregulatory and inflammatory processes. On chromosome 17 in region 17q11.2-q12 is the gene MCP1. The superfamily can be subdivided into 4 smaller groups, depending on the N-ter arangment of the cysteines.  The MCP1<ref>PMID:8170963</ref> is also known as '''chemokine (C-C motif) ligand''' or: <br>
+- MCP1 <br>
+- small inducible cytokine A2 (SCYA2)<br>
+- MCAF <br>
+- GDCF-2 <br>
+- SMC-CF <br>
+- HSMCR30 <br>
+- MGC9434 <br>
+- GDCF-2 <br>
+- HC11 <br>
-== Disease ==
+It exists as a monomer or a dimer, eventhough the homodimer form is preferred.
+The structure of the monomer is made of <scene name='72/721520/Ligand_binding_on_ccl2/2'>3 Beta sheets and 1 alpha helix</scene>.
-== Relevance ==
+== Action principle ==
+MCP1 is secreted thanks to variety of cells including endothelial cells, fibroblasts, epithelial, and  smooth muscle. It acts by attracting some of the immune cells like monocytes and lymphocytes. Theses cells are equipped with a CCR2 receptor coupled with a G protein which can recuits MCP1.
+MCP1 apply its chemotaxis power thanks to a concentration gradient : immune cells move from region with low concentration of MCP1 to region where a lot of MCP1 is secreted. Monocytes will then themselves be matured in macrophage which are able to secrete MCP1 in order to recruit more immune cells on the damage tissue.
+== Ligands ==
+To see the ligands it binds to, please show the <scene name='72/721520/Ligand_binding_on_ccl2/1'>monomer structure</scene> and then show the binding sites for <scene name='pdbligand=K:POTASSIUM+ION'>potassium</scene> and <scene name='pdbligand=PO4:PHOSPHATE+ION'>phosphate</scene> ions. The PO4 binds to the K35, S33 and S34 of the monomer and K binds to F15, N14 and N17.
+== Evolutionary Conservation ==
+[[Image:Consurf_key_small.gif|200px|right]]
+Check<jmol>
+  <jmolCheckbox>
+    <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/if/3ifd_consurf.spt"</scriptWhenChecked>
+    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
+    <text>to colour the structure by Evolutionary Conservation</text>
+  </jmolCheckbox>
+</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB].
+<div style="clear:both"></div>
+<div style="background-color:#fffaf0;">
+== Diseases ==
+MCP1 is implicated in several diseases like psoriasis and rheumatoid arthritis where the appear to recruit macrophages, therefore bolstering the inflammation on joints.
+It is thought to be involved in atherosclerosis in the recruitment of monocytes into the arterial wall as well as in prostate cancer<ref>PMID:25917126</ref>.
+It has also been found elevated in the urine of people with lupus as a sign warning of inflammation of the kidney.
+MCP1 is overexpressed in epilepsy, brain ischemia, Alzheimer's disease, EAE and traumatic brain injury.
 == Structural highlights ==
-This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.
+MCP1 is part of the C-C motif group because of the covalent bond made between <scene name='72/721520/Cv/4'>2 of the 4 cysteines of the N terminal domain</scene>.<ref>PMID:8989326</ref>
+Post translational modifications at the N-terminus can regulate receptor and target cell selectivity. Deletion of the N-terminal residue converts it from an activator of basophil to an eosinophil chemoattractant.
+</StructureSection>
+[[Image:chaine.png]]
+== Synthesis ==
+Thanks to a combination of solid phase peptide synthesis (SPPS) and native chemical ligation (NCL), MCP1 was synthesized. Its thioester-peptide segment was made using the sulfonamide safety-catch linker and 9-fluorenylmethoxycarbonyl (Fmoc) SPPS and that is probably one of the first crystal structures prepared using these techniques. To facilitate the synthesis of both MCP1 fragments, pseudoproline dipeptides were used. Then, NCL was used to assembly the all chain and MCP1 was folded and oxidized by a glutathione redox buffer.
+MCP1 was crystallized and the structure was determined by X-ray diffraction at 1.9-A resolution.
-</StructureSection>
 == References ==
+https://fr.wikipedia.org/wiki/CCL2
+http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/GetPage.pl?pdbcode=1DOK
+http://www.uniprot.org/uniprot/P13500#interaction
+http://www.rcsb.org/pdb/explore/explore.do?structureId=3IFD
 <references/>